<?xml version="1.0" encoding="UTF-8"?>
<sec id="sec3-9" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vesicle stability study</div>
 <p xmlns="http://www.w3.org/1999/xhtml">The physical stability of the selected formulations was assessed in terms of vesicles size as described earlier. According to the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) guidelines, Iran is categorized in zone II. As far as accelerated and intermediate testing condition is concerned, formulations were stored under three conditions such as 4 °C, 25 °C with relative humidity (RH) of 30%, and 40 °C with RH of 70% for 3 months (
  <a rid="ref22" ref-type="bibr" href="#ref22">22</a>). Then, vesicle sizes were examined during 24 h, 2 weeks, 1 and 3 months after preparation.
 </p>
</sec>
